Duloxetine Hydrochloride Patent Expiration
Duloxetine Hydrochloride was first introduced by Eli Lilly And Co
Duloxetine Hydrochloride Patents
Given below is the list of patents protecting Duloxetine Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Drizalma Sprinkle | US10413525 | Duloxetine sprinkles | Apr 13, 2037 | Sun Pharm |
| Drizalma Sprinkle | US10959982 | Duloxetine sprinkles | Apr 13, 2037 | Sun Pharm |
| Drizalma Sprinkle | US11202772 | Duloxetine sprinkles | Apr 13, 2037 | Sun Pharm |
| Drizalma Sprinkle | US12171742 | Duloxetine sprinkles | Apr 13, 2037 | Sun Pharm |
| Drizalma Sprinkle | US9839626 | Duloxetine sprinkles | Apr 13, 2037 | Sun Pharm |
| Cymbalta |
US6596756 (Pediatric) | Treatment of fibromyalgia |
Mar 10, 2020
(Expired) | Lilly |
| Cymbalta | US6596756 | Treatment of fibromyalgia |
Sep 10, 2019
(Expired) | Lilly |
| Cymbalta |
US5508276 (Pediatric) | Duloxetine enteric pellets |
Jan 18, 2015
(Expired) | Lilly |
| Cymbalta | US5508276 | Duloxetine enteric pellets |
Jul 18, 2014
(Expired) | Lilly |
| Cymbalta |
US5023269 (Pediatric) | 3-aryloxy-3-substituted propanamines |
Dec 11, 2013
(Expired) | Lilly |
| Cymbalta | US5023269 | 3-aryloxy-3-substituted propanamines |
Jun 11, 2013
(Expired) | Lilly |
Duloxetine Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List